Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Synthetic Hormones Industry?

There has been significant growth in the synthetic hormones market over the past few years. This market is projected to expand from $6.38 billion in 2024 to $6.71 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.1%. The growth during the historical period can be traced back to factors such as animal growth stimulation, performance improvement, environmental influence, fertility treatments, and management of menopause symptoms.

Over the upcoming years, the market size for synthetic hormones is projected to experience a stable growth, reaching a worth of “$7.98 billion in 2029” with a compound annual growth rate (CAGR) of 4.4%. The growth expected within this forecasting period can be credited to the broadening of transgender healthcare services, rising expenditure and coverage in healthcare, authorized approvals, and the widening use of synthetic hormones. Predicted trends within this period denote the ascent of plant-derived hormone treatment, incorporation of hormone therapy in anti-aging care, advancements in drug delivery technology, and an emphasis on birth control without the use of hormones.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

#Which Factors Are Currently Driving The Growth Of The Synthetic Hormones Market?

The surge in the occurrence of hormonal imbalances is anticipated to drive the expansion of the synthetic hormones market. Hormonal imbalance is characterized by a high or low level of a certain hormone in the bloodstream, an anomaly that can result from stress, age, certain diseases, or lifestyle choices, disrupting the normal generation and control of body hormones. Synthetic hormones are deployed to augment or replace natural hormones during hormonal imbalances, enabling regulation of bodily functions and the reduction of symptoms associated with hormonal deficiencies or oversupply. To illustrate, the NHS Business Services Authority, a non-departmental public body based in the UK, stated that around 7.80 million Hormone Replacement Therapy (HRT) items were prescribed in England in 2022, representing a 35.0% rise from the last year. Consequently, the surge in the occurrence of hormonal imbalances is fostering the expansion of the synthetic hormones market.

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Which Emerging Trends And Strategic Shifts Are Shaping The Synthetic Hormones Market?

Prominent players in the synthetic hormone industry are concentrating on product innovation, such as the recombinant human growth hormone, to improve their market profitability. The recombinant human growth hormone is an artificial hormone used for the treatment of growth hormone deficiencies in both children and adults, including other medical conditions related to growth hormone absence. For instance, in February 2022, Pfizer Inc., a US pharmaceutical firm, along with OPKO Health Inc., a US medical test and medication corporation, obtained marketing approval for their NGENLA (somatrogon) once-weekly injections in the European Union, aimed at treating pediatric growth hormone deficiency in children and adolescents aged at least three years old. This novel long-acting injection offers an alternative for individuals with growth disorders due to inadequate growth hormone secretion. Unlike daily growth hormone injections, NGENLA is injected subcutaneously and endures in the body longer, enabling its weekly administration.

Who Are The Main Participants Shaping The Synthetic Hormones Market Landscape?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Currently Holds The Largest Share In The Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model